The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults.
about
Purinergic signaling and human immunodeficiency virus/acquired immune deficiency syndrome: From viral entry to therapyImpact of antiretroviral therapy (ART) timing on chronic immune activation/inflammation and end-organ damageClinical Determinants of HIV-1B Between-Host Evolution and their Association with Drug Resistance in Pediatric PatientsThe CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recoveryBlimp-1-mediated CD4 T cell exhaustion causes CD8 T cell dysfunction during chronic toxoplasmosis.Clinical, immunological and treatment-related factors associated with normalised CD4+/CD8+ T-cell ratio: effect of naïve and memory T-cell subsetsHIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers.Enhanced immune activation linked to endotoxemia in HIV-1 seronegative MSM.CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients.Antiretroviral Regimens and CD4/CD8 Ratio Normalization in HIV-Infected Patients during the Initial Year of Treatment: A Cohort StudyNeurocognitive decline in HIV patients is associated with ongoing T-cell activation in the cerebrospinal fluid.A Low Peripheral Blood CD4/CD8 Ratio Is Associated with Pulmonary Emphysema in HIV.Identifying the white matter impairments among ART-naïve HIV patients: a multivariate pattern analysis of DTI data.CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapyImpact of HIV Infection and Anti-Retroviral Therapy on the Immune Profile of and Microbial Translocation in HIV-Infected Children in VietnamFirst-line cART regimen impacts the course of CD8+ T-cell counts in HIV-infected patients that achieve sustained undetectable viral load.Baseline Naive CD4+ T-cell Level Predicting Immune Reconstitution in Treated HIV-infected Late PresentersIncreased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio.Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals.Eradication of HIV and Cure of AIDS, Now and How?Paediatric HIV grows up: recent advances in perinatally acquired HIV.Human immunodeficiency virus type-1 induces a regulatory B cell-like phenotype in vitro.Immune recovery of middle-aged HIV patients following antiretroviral therapy: An observational cohort study.Thymic Function Impacts the Peripheral CD4/CD8 Ratio of HIV-Infected Subjects.Immunosenescence and hurdles in the clinical management of older HIV-patients.Decreased levels of Th17 cells are associated with invasion fungal infections after allogeneic hematopoietic stem cell transplantation.Different impact of raltegravir versus efavirenz on CD4/CD8 ratio recovery in HIV-infected patients.Asymptomatic CMV Replication During Early Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower CD4/CD8 Ratio During HIV Treatment.Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression.Longitudinal assessment of fractional anisotropy alterations caused by simian immunodeficiency virus infection: a preliminary diffusion tensor imaging study.Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy.Combining CD4 recovery and CD4: CD8 ratio restoration as an indicator for evaluating the outcome of continued antiretroviral therapy: an observational cohort study.Effects of Maraviroc versus Efavirenz in Combination with Zidovudine-Lamivudine on the CD4/CD8 Ratio in Treatment-Naive HIV-Infected Individuals.Dual therapy with etravirine plus raltegravir for virologically suppressed HIV-infected patients: a pilot study.Impact of Clinical Parameters in the Intrahost Evolution of HIV-1 Subtype B in Pediatric Patients: A Machine Learning ApproachIs weak CD4+ gain in the course of suppressive combination antiretroviral therapy for HIV infection a current clinical challenge? A case report and brief review of the literature.Cross-sectional study of CD4: CD8 ratio recovery in young adults with perinatally acquired HIV-1 infection.Changes in hematological indices and lymphocyte subsets in response to whole blood donation in healthy male donors.Axonal chronic injury in treatment-naïve HIV+ adults with asymptomatic neurocognitive impairment and its relationship with clinical variables and cognitive status.
P2860
Q26797749-7F77D627-B6EE-451B-8441-F9FD1145FDFEQ27014077-1BF14EFB-31D4-4B8D-883B-14EC9AFA3A9CQ28554672-089D3321-E4F8-4703-AEE1-5D122A79C7D4Q29307877-D62D67E2-99BB-40DE-AF2B-35332A0BE03AQ30276224-E21CE9EB-B4DC-478D-91CD-ACDB034C53F2Q33591190-C4510747-047A-49F8-AEED-9CC1DC5056F3Q33618542-22130BC2-B001-4CB2-AD6F-00A9E5F92C3EQ35545690-BF6C913F-48AC-4F1A-B662-A1995F5BDABBQ35701186-02A6E86A-D17E-4154-93C4-158A0A5901ADQ35801549-41AADF25-C5CF-4BCA-9E5B-CDCED1EA7B7FQ35814594-7A3932AC-7F70-4A9A-9CC1-B11D20D4F98AQ36072424-40A48AE9-8527-44CF-B0C0-E93EE61D2822Q36259851-CA25A05F-77A4-4407-9064-92D594AF079AQ36342740-512F1E91-A243-48D0-8C38-3E607D6C4ADBQ36671999-DDD0E1E7-3FD1-4A92-A3BB-1CCEA0D0CF9DQ37209955-BD6C8903-A5AF-43D5-B2EE-EAA4AFF3710FQ37354804-845739B9-1583-4C4F-8C46-A9DD5975CEBCQ37447469-03426FCD-540C-4D9A-BB22-8542E4CD0559Q37534052-FC8EAE4D-D3D2-4D38-94BD-D5A1B7C4B6A3Q37584487-824A8D16-4565-4FA3-818B-291BFBAD6065Q38154888-36810EC7-96FC-4ED6-933F-115C5F631AC3Q38245999-85228224-F853-4676-9B3A-475A08772A4FQ38676628-0305C141-2225-4549-BEF0-F034B1232C8EQ38682437-8DF691CB-79E0-4617-832F-2202604BA30EQ39093640-8739A3E3-FFD6-45F0-A26B-D6D7CF573AA6Q39170367-3A345404-5911-4728-9471-9518CBC8732DQ40062807-5879F2FD-65F2-440B-ABD9-F3BFE88C1FE1Q40531468-BF5292BD-6830-4107-943E-56725BEE8836Q40549489-30BF5F1F-578D-4415-A64F-6B37A1A7AA91Q40779840-4A6C96A3-5E5D-4B68-8BDE-9711E616C1A9Q40965527-CE8D35B2-22AE-43C8-8F81-A72A194C3214Q40989476-F8866700-24B2-4D09-A083-72BE0D0B2242Q41936053-02A41692-DA2F-4642-9508-93F227803A34Q41989387-08C10983-40F2-45F7-AD2A-ACE27CB9F8AAQ42244133-CE29CA1F-D614-4745-89F5-92E77991BB5CQ42675473-7A3C7A8A-152A-42F0-A595-8F2DC0F8E902Q47170671-1B697799-2863-435B-B981-1DAA627603DCQ49712180-86FA255D-BCCC-4FDA-AEBF-4CB38AC4C403Q50882919-6B8366BC-44E6-48D5-9F15-E4EB14698C8CQ54985207-1E091B84-3E05-4EA0-BCF2-5C8146C79058
P2860
The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The CD4/CD8 ratio as a marker ...... ted children and young adults.
@en
The CD4/CD8 ratio as a marker ...... ted children and young adults.
@nl
type
label
The CD4/CD8 ratio as a marker ...... ted children and young adults.
@en
The CD4/CD8 ratio as a marker ...... ted children and young adults.
@nl
prefLabel
The CD4/CD8 ratio as a marker ...... ted children and young adults.
@en
The CD4/CD8 ratio as a marker ...... ted children and young adults.
@nl
P2093
P50
P1433
P1476
The CD4/CD8 ratio as a marker ...... ted children and young adults.
@en
P2093
José T Ramos
Laura Díaz
María Dolores Gurbindo
María Isabel González Tomé
María Isabel de José
María José Mellado
Santiago Moreno
P304
P356
10.1097/QAD.0B013E32835FAA72
P407
P577
2013-06-01T00:00:00Z